r&d

The paper studies R&D investment decisions of a firm facing the threat of new technology entry and subject to technical uncertainty. The authors distinguish four scenarios: inevitable entry, entry deterrence, entry blockade, and non-credible entry threat.

The paper discusses the properties of scientific and technological knowledge and the institutions supporting its generation and its economic applications.

Using Monte Carlo techniques, the authors model how future price controls in the U.S. will impact early-stage product development decisions in the pharmaceutical industry.

This paper presents the results from multiple case studies on managing knowledge through collaboration currently in use at three university research units.

The authors use the geographic distribution of the research activities of the major global pharmaceutical firms to explore the extent to which knowledge spills over from proximate private and public institutions. Results indicate that spillovers exist and are significant.

The authors introduce an alternative way of modeling spillovers, focusing on the design of the research and development process. According to the authors, in their model the spillovers depend on the compatibility between firms’ technologies.

The study analyses the role played by adjustment costs and research and development (R&D) investment prices in total R&D productivity. The results show that on average, for each monetary unit increase in adjustment costs produces a fall in productivity of 0.034 monetary units.

The action plan highlights that despite significant strides in increasing public investment in research and development over the last five years, the performance of research and development (R&D) in key sectors of the Irish economy is low compared with leading knowledge based economies. The plan calls for a step change in the R&D performance, particularly in the enterprise sector, in order to sustain employment and competitiveness in an increasingly global knowledge-based economy.

There are two central issues within this paper. First how does the exogenous increment in knowledge
capital determine current aggregate R&D effort or in the size of the R&D sector and secondly, how do parameters feed into the determination of the rate of expected growth?

The authors provide new insights into how the internationalisation of R&D of these Finnish multinationals is also reflected in their innovative output as measured by patenting. The results indicate that inventor teams have grown in size over time, especially through the entry of U.S., German, Swedish and U.K. inventors.